BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27912890)

  • 1. Persistence of
    Piña IL; Carson P; Lindenfeld J; Archambault WT; Jacobson AF
    Am J Cardiol; 2017 Feb; 119(3):434-439. PubMed ID: 27912890
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study.
    Narula J; Gerson M; Thomas GS; Cerqueira MD; Jacobson AF
    J Nucl Med; 2015 Jul; 56(7):1011-8. PubMed ID: 26069309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic usefulness of planar
    Agostini D; Ananthasubramaniam K; Chandna H; Friberg L; Hudnut A; Koren M; Miyamoto MI; Senior R; Shah M; Travin MI; Dahl JV; Chen K; Levy WC;
    J Nucl Cardiol; 2021 Aug; 28(4):1490-1503. PubMed ID: 31468379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure.
    Clements IP; Kelkar AA; Garcia EV; Butler J; Chen J; Folks R; Jacobson AF
    Eur Heart J Cardiovasc Imaging; 2016 Apr; 17(4):384-90. PubMed ID: 26588983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
    Ikeda-Yorifuji I; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Fukuhara E; Abe M; Nakamura J; Fukunami M
    J Nucl Cardiol; 2020 Jun; 27(3):992-1001. PubMed ID: 30761485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure.
    Jacobson AF; White S; Travin MI; Tseng C
    Nucl Med Commun; 2017 Feb; 38(2):141-148. PubMed ID: 27861299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal dysfunction does not affect the prognostic value of myocardial iodine-123 meta-iodobenzylguanidine imaging in heart failure.
    Malhotra S; Wang L; Bunker CH; Winger D; Soman P
    Nucl Med Commun; 2014 Jan; 35(1):58-63. PubMed ID: 24177039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.
    Sood N; Al Badarin F; Parker M; Pullatt R; Jacobson AF; Bateman TM; Heller GV
    J Nucl Cardiol; 2013 Oct; 20(5):813-20. PubMed ID: 23864400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Cardiac
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Kayama K; Kawahira M; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):655-668. PubMed ID: 34656490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
    Nakata T; Wakabayashi T; Kyuma M; Takahashi T; Tsuchihashi K; Shimamoto K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):186-94. PubMed ID: 15452671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
    García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
    Narita M; Kurihara T
    J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis.
    Verschure DO; Veltman CE; Manrique A; Somsen GA; Koutelou M; Katsikis A; Agostini D; Gerson MC; van Eck-Smit BL; Scholte AJ; Jacobson AF; Verberne HJ
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):996-1003. PubMed ID: 24686260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.
    Jacobson AF; Lombard J; Banerjee G; Camici PG
    J Nucl Cardiol; 2009; 16(1):113-21. PubMed ID: 19152136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.